Page 40 - Alkermes News Today

Mizuho Securities analyst Uy Ear maintained a Buy rating on Alkermes (ALKS – Research Report) yesterday and set a price target of $37.00. ...

NORTHAMPTON, MA / ACCESSWIRE / April 20, 2023 / AlkermesAlcohol Use Disorder (AUD) does not discriminate. But some communities are disproportionately affected. As we recognize both National Minority Health

- Application Period to Begin on May 1, 2023 - DUBLIN, April 19, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the company will accept applications for its Alkermes

[323 Pages Report] The global substance use disorder treatment market is forecasted to be estimated at US$ 14 Mn by 2032, up from US$ 7 Mn in 2022, advancing at a CAGR of 5.4% during the forecast period.Substance Use Disorder Treatment Market: OverviewThe global market for substance use disorder treatment is expecte...

– Application Period to Begin on May 1, 2023 – DUBLIN, April 19, 2023 /PRNewswire/ -- Alkermes plc today announced that the company will accept applications for its Alkermes Inspiration... | April 19, 2023

DUBLIN, April 19, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Wednesday, April 26, 2023 to discuss

DUBLIN, April 19, 2023 /PRNewswire/ -- Alkermes plc will host a conference call and webcast presentation at 8:00 a.m. ET on Wednesday, April 26, 2023 to discuss the companys first quarter... | June 19, 2023

DUBLIN, April 18, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it has submitted a confidential draft Form 10 registration statement to the United States Securities and

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it has submitted a confidential draft Form 10 registration statement to the United States...

A new meta-analysis identifies specific brain regions involved in treatment response in bipolar and borderline personality disorders, potentially paving the way for more targeted treatment.